AustraliaHealth

Mesoblast (ASX:MSB) has acquired an exclusive worldwide licence for a chimeric antigen receptor technology platform.

AVITA Medical (ASX:AVH) unveiled interim data from its Cohealyx-I multi-centre study.

Ryman Healthcare (ASX:RYM) reported a 10% lift in Q4 sales, meeting FY26 guidance despite village closures.

Telix Pharmaceuticals (ASX:TLX) announced the launch of a US$550 million offering of senior unsecured convertible notes due 2031.

PainChek (ASX:PCK) announced a master services agreement with Sabra Health Care REIT (NASDAQ:SBRA).

Noxopharm (ASX:NOX) has announced the resignation of its CEO and Managing Director, Dr Gisela Mautner.

Entropy Neurodynamics (ASX:ENP) announced a pivotal breakthrough in its TRP-8803 clinical programme.

Clarity Pharmaceuticals (ASX:CU6) has announced a landmark commercial manufacturing agreement with Nucleus RadioPharma.

Monash IVF Group (ASX:MVF) has entered a critical period of negotiation following a revised, non-binding indicative proposal from a high-profile consortium.

Talius Group (ASX:TAL) has secured a master services agreement with Seventh-Day Adventist Aged Care (South Queensland).

Pro Medicus (ASX:PME) announced a five-year contract renewal with Chicago-based Northwestern Medicine.

Telix Pharmaceuticals (ASX:TLX) and Regeneron Pharmaceuticals (NASDAQ:REGN) have announced a global collaboration.